Sheehan Syndrome: Definition and Pathophysiology
Sheehan syndrome is postpartum pituitary necrosis leading to hypopituitarism, caused by severe hemorrhage during delivery that results in ischemic necrosis of the enlarged pituitary gland. 1, 2
Underlying Mechanism
The pathophysiology involves several key factors:
Pituitary vulnerability during pregnancy: The pituitary gland enlarges significantly during pregnancy (up to 135% of normal size), increasing its metabolic demands while blood supply remains relatively unchanged, making it particularly susceptible to ischemic injury 2
Precipitating event: Massive postpartum hemorrhage (PPH) causes severe hypotension and hypovolemic shock, leading to impaired blood perfusion to the already vulnerable enlarged pituitary gland 1, 2, 3
Predisposing anatomical factors: Small sella turcica size, vasospasms triggered by PPH, and/or thrombosis associated with pregnancy or coagulation disorders increase susceptibility to pituitary necrosis 2
Progressive autoimmune component: Autoimmunity may contribute to the progressive worsening of pituitary function over time following the initial ischemic insult 2
Clinical Presentation Patterns
The syndrome manifests in two distinct temporal patterns:
Chronic Presentation (Most Common)
- Symptoms typically become evident years or even decades after the precipitating delivery, with diagnostic delays of 10-30 years being common 1, 2, 4
- Nonspecific symptoms include chronic fatigue, failure to lactate postpartum, amenorrhea (cessation of menses), cold intolerance, and progressive weakness 2, 5
Acute Presentation (Rare but Life-Threatening)
- Can develop within days after delivery (median 7-9 days for adrenal insufficiency manifestations) 3
- Presents with sudden onset seizures, altered consciousness or coma, severe hypoglycemia, and acute adrenal crisis 6, 3
- Requires immediate recognition and treatment to prevent mortality 3
Hormonal Deficiency Pattern
The pattern of hormone deficiency follows the anatomical distribution of hormone-secreting cells relative to the pituitary vasculature: 2
- Most commonly affected first: Growth hormone (GH) and prolactin deficiency—manifesting as failure to lactate postpartum 2, 5
- Intermediate severity: Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) deficiency—causing amenorrhea and infertility 2
- Severe necrosis required: Thyroid-stimulating hormone (TSH) and adrenocorticotropic hormone (ACTH) deficiency—the latter being potentially life-threatening if unrecognized 2, 3
Epidemiology and Risk Context
- Developing countries: Remains an important cause of hypopituitarism due to inadequate obstetric care and higher rates of uncontrolled PPH 2, 5
- Developed countries: Has become rare due to improved obstetric management, but should still be considered in any woman with hypopituitarism and history of PPH 6, 2, 4
- The condition is frequently overlooked even when present, leading to significant diagnostic delays and preventable morbidity 1, 4
Diagnostic Approach
Diagnosis requires three key elements: 2, 5
- Clinical history: History of severe postpartum hemorrhage requiring transfusion, with failure to lactate and amenorrhea following delivery 2, 5
- Hormonal confirmation: Low or absent levels of pituitary hormones with inadequate response to stimulation tests 2
- Imaging findings: MRI typically shows empty sella turcica or small pituitary gland; acute cases may show serial changes on MRI including initial enlargement followed by involution 4, 3
Critical Clinical Pearls
Clinicians must maintain high suspicion in specific scenarios: 6, 3
- Any woman with history of massive PPH who develops unexplained altered mental status, seizures, or shock in the postpartum period requires immediate evaluation for acute Sheehan syndrome 3
- In placenta accreta spectrum cases with significant blood loss, attention to the "small but real possibility" of Sheehan syndrome is warranted given the clinical scenario and potential for hypoperfusion 6
- The triad of postpartum hemorrhage, failure to lactate, and amenorrhea should immediately trigger evaluation for Sheehan syndrome 5
Management Principles
Treatment consists solely of lifelong hormone replacement therapy: 1, 2, 4
- Immediate glucocorticoid replacement is critical to prevent life-threatening adrenal crisis 2, 3
- Thyroid hormone replacement (thyroxine) for TSH deficiency 4, 3
- Sex hormone replacement for gonadotropin deficiency 4
- Growth hormone replacement may improve quality of life, cardiovascular risk, and bone density 4
Early diagnosis and appropriate treatment significantly reduce morbidity and mortality, improve general energy, physical capacity, temperature regulation, and prevent potentially fatal adrenal crises. 1, 4, 5